Henri M.H. Spronk
机构: Associate Professor Biochemistry, Maastricht University
每年引用次数
引用次数
引用: 13,987
H-指数: 59
I10-指数 : 167
出版物: 424
The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus.
Eelco W Meesters , Hjalmar Hansen , Henri MH Spronk , Karly Hamulyak
Blood Coagulation & Fibrinolysis 18 ( 1) 21 -28
37
2007
Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice.
Hjalmar R Hansen , Jef L Wolfs , Lois Bruggemann , Dirkje W Sommeijer
Blood Coagulation & Fibrinolysis 18 ( 7) 627 -636
12
2007
The procoagulant effects of fine particulate matter in vivo
Evren Kilinç , Holger Schulz , Gerhardus JAJM Kuiper , Henri MH Spronk
Particle and Fibre Toxicology 8 ( 1) 12
13
2011
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
Oliver Grottke , Joanne van Ryn , Henri MH Spronk , Rolf Rossaint
Critical Care 18 ( 1) 1 -10
82
2014
Blood coagulation and the risk of atherothrombosis: a complex relationship
Henri MH Spronk , Danielle van der Voort , Hugo ten Cate
Thrombosis Journal 2 ( 1) 12 -12
91
2004
Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes
Dirkje W Sommeijer , René van Oerle , Pieter H Reitsma , Janneke J Timmerman
Thrombosis Journal 3 ( 1) 12 -12
27
2005
Coagulation factor Xa induces proinflammatory responses in cardiac fibroblasts via activation of protease-activated receptor-1
Elisa D’Alessandro , Billy Scaf , Chantal Munts , Arne van Hunnik
Cells 10 ( 11) 2958
3
2021
Integrating mechanisms in thrombotic peripheral arterial disease
Magdolna Nagy , Paola EJ van der Meijden , Julia Glunz , Leon Schurgers
Pharmaceuticals 15 ( 11) 1428 -1428
4
2022
Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease.
Renske H Olie , Paola EJ van der Meijden , Henri MH Spronk , Rene van Oerle
TH open : companion journal to thrombosis and haemostasis 3 ( 3)
3
2019
Plasma Kallikrein as a forgotten clotting factor
Katherine J Kearney , Henri MH Spronk , Jonas Emsley , Nigel S Key
Seminars in Thrombosis and Hemostasis
5
2023
Thrombin generation in cardiovascular disease and mortality–results from the Gutenberg Health Study
Pauline CS van Paridon , Marina Panova-Noeva , Rene van Oerle , Andreas Schulz
Haematologica 105 ( 9) 2327 -2327
41
2020
Part 1: Thrombin Generation Chapter 2: Thrombin Generation in Cardiovascular Disease and Mortality-Results from the Gutenberg Health Study
Pauline CS van Paridon , Marina Panova-Noeva , Rene van Oerle , Andreas Schultz
Markers of Hypercoagulation in Cardiovascular Disease in the General Population 22 -22
Blood coagulation and beyond: position paper from the Fourth Maastricht Consensus Conference on Thrombosis
Asim Cengiz Akbulut , Ryanne A Arisz , Constance CFMJ Baaten , Gaukhar Baidildinova
Thrombosis and haemostasis 123 ( 08) 808 -839
5
2023
Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study
Vicente Artola Arita , Martijn E Van De Lande , Neda Khalilian Ekrami , Bao-Oanh Nguyen
Europace 25 ( 4) 1323 -1331
4
2023
Social Media Associate Editors
Mary Cushman , Cihan C Ay , Pantep Angchaisuksiri , Suzanne Cannegieter
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis
Kathryn M Musgrave , Jonathan Scott , Wezi Sendama , Aaron I Gardner
Thrombosis Research 228 10 -20
3
2023
Clinical and Poulation Studies
Hanneke JBH Beijers , Isabel Ferreira , Henri MH Spronk , Bert Bravenboer
Arterioscler Thromb Vasc Biol 30 2639 -2647
2010
Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model
Markus Honickel , Benjamin Maron , Joanne van Ryn , Till Braunschweig
Thrombosis and Haemostasis 115 ( 02) 271 -284
42
2016
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment
Hugo Ten Cate , Tomasz J Guzik , John Eikelboom , Henri MH Spronk
Cardiovascular research 117 ( 9) 2030 -2044
36
2021